Brand and Other Names:Scleromate
- Classes: Sclerosing Agents
Dosing & Uses
Dosage Forms & Strengths
Obliteration of Varicose Veins
May use test dose of 0.25-1 mL of 5% solution
Small/medium Veins: 50-100 mg IV
Large Veins: 150-250 mg IV
May repeat q5-7Days
Frequency Not Defined
Burning or cramping sensations
Injection site reactions
Persistent deep vein occlusion
Acute superficial thrombophlebitis; underlying arterial disease
Varicosities caused by abdominal & pelvic tumors
Uncontrolled DM, thyrotoxicosis, TB, neoplasms, asthma, sepsis, blood dyscrasias, acute respiratory or skin disease
Delay in patients with acute local or systemic infections
Extensive therapy inadvisable in severely debilitated/senile patients
Extravasation may cause tissue necrosis
Pregnancy & Lactation
Pregnancy Category: N/A (no info)
A:Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B:May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.
C:Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.
D:Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.
X:Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.
NA:Information not available.
Mechanism of Action
Sclerosing agent, causes inflammation of vascular intimal layer and consequent thrombus formation
May use a test dose (0.25-1 mL) first to determine sensitivity
If solid matter present, warm ampule by immersing in hot water until clear
Because injection froths easily, a large bore needle should be used to fill syringe
Use smaller bore needle for injection
May give dose as single or multiple injections
Store at 15-30°C
Do not expose to air
Do not freeze
To view formulary information first create a list of plans. Your list will be saved and can be edited at any time.
Adding plans allows you to:
- View the formulary and any restrictions for each plan.
- Manage and view all your plans together – even plans in different states.
- Compare formulary status to other drugs in the same class.
- Access your plan list on any device – mobile or desktop.
The above information is provided for general informational and educational purposes only. Individual plans may vary and formulary information changes. Contact the applicable plan provider for the most current information.
|1||This drug is available at the lowest co-pay. Most commonly, these are generic drugs.|
|2||This drug is available at a middle level co-pay. Most commonly, these are "preferred" (on formulary) brand drugs.|
|3||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs.|
|4||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.|
|5||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.|
|6||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.|
|NC||NOT COVERED – Drugs that are not covered by the plan.|
Drugs that require prior authorization. This restriction requires that specific clinical criteria be met prior to the approval of the prescription.
Drugs that have quantity limits associated with each prescription. This restriction typically limits the quantity of the drug that will be covered.
Drugs that have step therapy associated with each prescription. This restriction typically requires that certain criteria be met prior to approval for the prescription.
Drugs that have restrictions other than prior authorization, quantity limits, and step therapy associated with each prescription.
Select a box to add or remove a plan.
Select a class to view formulary status for similar drugs